DYN Earnings Dyne Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.73 | 2026-05-11 | 10-Q |
| FY 2025 | 2025-12-31 | -3.47 | 2026-03-02 | 10-K |
| Q3 2025 | 2025-09-30 | -2.74 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.02 | 2025-07-28 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.05 | 2026-05-11 | 10-Q |
| FY 2025 | 2024-12-31 | -3.37 | 2026-03-02 | 10-K |
| Q3 2025 | 2024-09-30 | -2.49 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.51 | 2025-07-28 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.81 | 2025-05-08 | 10-Q |
| FY 2025 | 2023-12-31 | -3.95 | 2026-03-02 | 10-K |
| Q3 2024 | 2023-09-30 | -2.86 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.88 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.78 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | -3.23 | 2025-02-27 | 10-K |
| Q3 2023 | 2022-09-30 | -2.50 | 2023-10-30 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.70 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.69 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -2.93 | 2023-03-02 | 10-K |
| Q3 2022 | 2021-09-30 | -1.92 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.09 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.